header API report 540x680@2x
NICE INSIGHT REPORT

Active Pharmaceutical Ingredients:
2023 Market Analysis, CDMO Pricing and Benchmarking

Coming September, 2023
  • 2023 pricing comparison for CDMO costs and services
  • 120 pages of API market research for your team
  • Over 60 company profiles of significant API CDMOs
  • Scientific analysis from CDMO owners, PhDs and executives
  • Unique insights into API development and manufacturing trends
header API report 540x680@2x

Key market insights for innovators, CDMOs and investors in the Active Pharmaceutical Ingredient industry.

01 analytics icon 65x65@2x-2

Stay ahead of the ever-changing API market — from emerging products, manufacturing changes and regulatory trends

The API market is constantly evolving on three fronts:  product, development and manufacturing. Stay ahead of all three with our comprehensive report. Leaders in API manufacturing use our Market Analysis for an unobstructed report of the modalities receiving funding and the technology getting medicine to patients more efficiently. 
02 report icon 65x65@2x-2

Make informed decisions with our extensive pricing study

The Market Analysis provides exclusive pricing research that is invaluable to API manufacturers. Benchmark your business against your peers, and effectively strategize for the future of manufacturing with up-to-date pricing info.

Coming September, 2023

The Market Analysis is the only report that combines scientific expertise with strategic business insights for a competitive advantage.

Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking provides

01 research icon 65x65@2x
Over 60 company profiles
for competitive analysis — includes capabilities, proprietary technologies and location
02 benchmarks icon 65x65@2x
API manufacturing pricing study
to benchmark against your peers with historical and current primary data
03 data analytics icon 65x65@2x
Expert analysis
on the new leading indications and why they’re appealing to investors
04 gears icon 65x65@2x
New analytical technology
and how data is leading a manufacturing revolution
05 pie chart icon 65x65@2x
Manufacturing trends
and the new technologies getting patients the drugs they need
06 report icon 65x65@2x
API regulation
and how businesses are staying strictly compliant

Over 750 hours of data collection and analysis including
primary pricing information and one-on-one interviews with API leaders.

Table of Contents

Executive Summary

Study Methodology

Section I:

API Market Overview

  • Size and Growth Rate
  • Branded/Generic
  • Sourcing Issues

Section II:

API Market Trends

  • Leading Indications
  • Orphan Drugs
  • Personalized Medicine
  • Highly Potent APIs
  • Controlled Substances
  • Novel Modalities/Mechanisms of Action/Compound Classes
  • Generics

Section III:

API Development Trends

  • Quality-by-Design
  • High-Throughput Screening
  • Scale-Down Modeling

Section IV:

API Manufacturing Trends

  • Rising Complexity and Expertise and Equipment Specialization
  • Green Processing
  • Chiral Technologies
  • Advances in Chemocatalytic Solutions
  • Advances in Enzymatic Technologies
  • Low-Temperature and High-Pressure Processes
  • Advances in Purification – Extraction, Filtration, Crystallization
  • Small-Volume Manufacturing
  • Automation
  • Process Intensification

Section V:

Continuous Processing API Analytical Trends

  • Inline/At-line/Online Monitoring
  • Digitalization of Analytical Data
  • Volume and Complexity Challenges
  • Multimodal View

Section VI:

API Regulatory Trends

  • Quality Assurance
  • Manufacturing Changes
  • Risk-Based Approaches
  • Traceability, Security, and Non-Corruptibility of Data
  • Supply Chain Assurance
  • Virtual Audits

Section VII:

API Contract Development and Manufacturing Market

  • Overall Market Size and State – Clinical and Commercial
  • API Outsourcing Trends – Shift to Local/Regional Suppliers
  • Recent Investments
  • Regional Analysis
  • Competitive Landscape

Section VIII:

API Outsourced Manufacturing Pricing Study

Section IX:

APIs CDMO Overview

Appendix I:

References

API report form
Coming September, 2023
Request your copy of the 2023 Active Pharmaceutical Ingredient Report

API report form